相关实验视频

Updated: Jun 22, 2025

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

循环RNAcircPHF16通过隔离miR-378a-3p来增强IL-17A的表达和分泌,以激活Graves病中的IL6ST轴

Zhengrong Jiang¹, Linghong Huang¹, Huiyao Cai¹

¹Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian, China.

|July 4, 2024

概括

循环RNAcircPHF16在格雷夫斯病 (GD) 中高度表达,并通过调节miR-378a-3p/IL6ST通路来促进互白素-17A (IL-17A) 的产生. 这一发现将circPHF16确定为GD的潜在治疗标.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

洲际蛋白-17A (IL-17A) 涉及到格雷夫斯病 (GD) 病原发生.
循环RNAs (circRNAs) 调节自身免疫性疾病中的IL-17A,但它们在GD T细胞中的作用尚不清楚.

研究的目的:

调查circRNAs在Graves病中的IL-17A调节中的作用.
确定特定的circRNAs参与IL-17A表达在GD T淋巴细胞.

主要方法:

在GD患者样本中的量化circPHF16表达 (PBMC,血清).
进行了体外实验 (Jurkat T 细胞) 用circPHF16沉默和过度表达.
使用生物信息学来预测和分析调节途径 (circPHF16/miR-378a-3p/IL6ST).
在Graves病的小鼠模型中验证了这些发现.

主要成果:

在GD患者中,circPHF16表达显著升高.
沉默circPHF16减少了IL-17A的表达和分泌在体外.
过度表达circPHF16增加了IL-17A水平.
发现了一种新型通路 (circPHF16/miR-378a-3p/IL6ST),将circPHF16与IL-17A调节联系起来.
在体内研究证实了这些分子表达趋势.

结论:

circPHF16在格雷夫斯病中充当IL-17A的积极调节者.
环PHF16/miR-378a-3p/IL6ST通路对于GD中的IL-17A调节至关重要.
circPHF16代表了潜在的诊断生物标志物和格雷夫斯病的治疗点.

关键词:

格雷夫斯的疾病.IL6STST 在线阅读环形PHF1616 的情况.在 miR-378a-3pp 中.

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...